ArticleHuman molecular genetics2016

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.

Asaf Wyszynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.